MENU
+Compare
ORGO
Stock ticker: NASDAQ
AS OF
Dec 23, 04:59 PM (EDT)
Price
$3.17
Change
+$0.12 (+3.93%)
Capitalization
374.78M

ORGO Organogenesis Holdings Forecast, Technical & Fundamental Analysis

a financial conglomerate

ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for ORGO with price predictions
Dec 20, 2024

ORGO's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for ORGO moved out of overbought territory on November 14, 2024. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 instances where the indicator moved out of the overbought zone. In of the 23 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 04, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on ORGO as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ORGO turned negative on November 29, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

ORGO moved below its 50-day moving average on December 18, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ORGO crossed bearishly below the 50-day moving average on December 20, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ORGO entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ORGO advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .

ORGO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ORGO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.331) is normal, around the industry mean (58.252). P/E Ratio (70.250) is within average values for comparable stocks, (90.460). ORGO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.861) is also within normal values, averaging (19.472).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ORGO is expected to report earnings to fall 113.89% to -1 cents per share on February 26

Organogenesis Holdings ORGO Stock Earnings Reports
Q4'24
Est.
$-0.01
Q3'24
Beat
by $0.11
Q2'24
Missed
by $0.14
Q1'24
Beat
by $0.01
Q4'23
Beat
by $0.01
The last earnings report on November 12 showed earnings per share of 9 cents, beating the estimate of -1 cents. With 207.25K shares outstanding, the current market capitalization sits at 374.78M.
A.I. Advisor
published General Information

General Information

a financial conglomerate

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Financial Conglomerates
Address
85 Dan Road
Phone
+1 781 575-0775
Employees
862
Web
https://www.organogenesis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRSRX49.230.46
+0.94%
Neuberger Berman Sustainable Equity R6
OANBX36.180.27
+0.75%
Oakmark Equity and Income Institutional
HDQVX15.12N/A
N/A
Janus Henderson Responsible Intl DivS
GAIGX22.36-0.12
-0.53%
Gabelli International Growth A
MFCCX34.27-0.88
-2.50%
Meridian Contrarian C

ORGO and Stocks

Correlation & Price change

A.I.dvisor tells us that ORGO and AMRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORGO and AMRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-1.93%
AMRX - ORGO
32%
Poorly correlated
+0.39%
HROW - ORGO
30%
Poorly correlated
-0.61%
ACET - ORGO
29%
Poorly correlated
+5.78%
AMPH - ORGO
27%
Poorly correlated
-0.63%
HTSUF - ORGO
26%
Poorly correlated
N/A
More